{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:16:24Z","timestamp":1791918984632,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25GM109441"],"award-info":[{"award-number":["R25GM109441"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.nbd.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T11:42:50Z","timestamp":1558093370000},"page":"118-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor"],"prefix":"10.1016","volume":"129","author":[{"given":"Chelsy R.","family":"Eddings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Arbez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7135-0361","authenticated-orcid":false,"given":"Sergey","family":"Akimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Geva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.05.009_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-319-50174-1_11","article-title":"Sigma-1 receptor agonists and their clinical implications in neuropsychiatric disorders","volume":"964","author":"Albayrak","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2019.05.009_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brainresbull.2011.03.019","article-title":"Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats","volume":"85","author":"Allahtavakoli","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2019.05.009_bb0015","doi-asserted-by":"crossref","first-page":"19238","DOI":"10.1074\/jbc.M117.782300","article-title":"Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity","volume":"292","author":"Arbez","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.05.009_bb0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.expneurol.2010.12.018","article-title":"Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration","volume":"228","author":"Baydyuk","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.05.009_bb0025","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI43992","article-title":"Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice","volume":"121","author":"Cazorla","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2019.05.009_bb0030","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"de Yebenes","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.05.009_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2009.11.025","article-title":"The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties","volume":"628","author":"Dyhring","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.05.009_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2017.10.001","article-title":"Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease","volume":"298","author":"Francardo","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.05.009_bb0045","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddw238","article-title":"Pridopidine activates neuroprotective pathways impaired in Huntington disease","volume":"25","author":"Geva","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2019.05.009_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.05.009_bb0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2019.05.009_bb0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes","volume":"11","author":"HD iPSC Consortium","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2019.05.009_bb0065","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice","volume":"20","author":"HD iPSC Consortium","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.05.009_bb0070","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/mds.25362","article-title":"A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease","volume":"28","author":"Huntington Study Group HART Investigators","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2019.05.009_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-018-0259-3","article-title":"Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse","volume":"13","author":"Kusko","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2019.05.009_bb0080","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of tau hyperphosphorylation and Abeta(1)(-)(4)(2) generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and sigma(1) receptor agonist, in a nontransgenic mouse model of Alzheimer's disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2019.05.009_bb0085","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1046\/j.1460-9568.2003.02950.x","article-title":"Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice","volume":"18","author":"Langa","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.05.009_bb0090","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2019.05.009_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2019.05.009_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nbd.2014.11.005","article-title":"Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease","volume":"74","author":"Miki","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2019.05.009_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2014.12.005","article-title":"Role of sigma-1 receptors in neurodegenerative diseases","volume":"127","author":"Nguyen","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2019.05.009_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/0024-3205(93)90588-T","article-title":"NE-100, a novel sigma receptor ligand: in vivo tests","volume":"53","author":"Okuyama","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2019.05.009_bb0115","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","article-title":"Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease","volume":"75","author":"Perez-Navarro","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.05.009_bb0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nbd.2013.10.010","article-title":"Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation","volume":"62","author":"Peviani","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.05.009_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JHD-170262","article-title":"Clinical trials corner: September 2017","volume":"6","author":"Rodrigues","year":"2017","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.nbd.2019.05.009_bb0130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2019.05.009_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jphs.2014.11.011","article-title":"The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration","volume":"127","author":"Ruscher","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2019.05.009_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2016.10.006","article-title":"The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease","volume":"97","author":"Ryskamp","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.05.009_bb0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/mp.2012.3","article-title":"The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the sigma-1 receptor","volume":"18","author":"Sahlholm","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2019.05.009_bb0150","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1007\/s00213-015-3997-8","article-title":"Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses","volume":"232","author":"Sahlholm","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2019.05.009_bb0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fphar.2018.00338","article-title":"Pridopidine reverses phencyclidine-induced memory impairment","volume":"9","author":"Sahlholm","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2019.05.009_bb0160","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.05.009_bb0165","doi-asserted-by":"crossref","first-page":"23318","DOI":"10.1074\/jbc.M112.349142","article-title":"Expression of a truncated form of the endoplasmic reticulum chaperone protein, sigma1 receptor, promotes mitochondrial energy depletion and apoptosis","volume":"287","author":"Shioda","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.05.009_bb0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/1871527315666161107093047","article-title":"Neurotrophin receptor signaling as a therapeutic target for Huntington's disease","volume":"16","author":"Simmons","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2019.05.009_bb0175","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/jcmm.12604","article-title":"Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6\/2 mouse model","volume":"19","author":"Squitieri","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2019.05.009_bb0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The Sigma-1 receptor as a pluripotent modulator in living systems","volume":"37","author":"Su","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2019.05.009_bb0185","first-page":"1461","article-title":"Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders","volume":"18","author":"Tsai","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.nbd.2019.05.009_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.1305-11.2012","article-title":"Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin","volume":"32","author":"Waldron-Roby","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.05.009_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088284","article-title":"Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity","volume":"9","author":"Watkin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2019.05.009_bb0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118306120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118306120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:13:03Z","timestamp":1760850783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118306120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"alternative-id":["S0969996118306120"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.05.009","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}